Twist Bioscience Corp Stock Fundamentals
| TWST Stock | USD 51.14 1.62 3.27% |
Twist Bioscience Corp fundamentals help investors to digest information that contributes to Twist Bioscience's financial success or failures. It also enables traders to predict the movement of Twist Stock. The fundamental analysis module provides a way to measure Twist Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Twist Bioscience stock.
Twist |
Twist Bioscience Corp Company Return On Equity Analysis
Twist Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Twist Bioscience Return On Equity | -0.38 |
Most of Twist Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Twist Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Twist Bioscience Corp has a Return On Equity of -0.3836. This is 98.4% lower than that of the Biotechnology sector and 94.26% lower than that of the Health Care industry. The return on equity for all United States stocks is 23.74% higher than that of the company.
Twist Bioscience Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Twist Bioscience competition to find correlations between indicators driving Twist Bioscience's intrinsic value. More Info.Twist Bioscience Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Twist Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Twist Bioscience's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics of similar companies.Twist Bioscience is currently under evaluation in return on equity category among its peers.
Twist Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.75) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | 2.76 B | ||||
| Shares Outstanding | 59.58 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 9.18 M | ||||
| Price To Book | 6.24 X | ||||
| Price To Sales | 9.99 X | ||||
| Revenue | 312.97 M | ||||
| Gross Profit | 119.64 M | ||||
| EBITDA | (176.71 M) | ||||
| Net Income | (208.73 M) | ||||
| Cash And Equivalents | 504.97 M | ||||
| Cash Per Share | 8.93 X | ||||
| Total Debt | 85.03 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | 8.39 X | ||||
| Cash Flow From Operations | (64.09 M) | ||||
| Short Ratio | 15.97 X | ||||
| Earnings Per Share | (3.60) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 52.14 | ||||
| Number Of Employees | 919 | ||||
| Beta | 1.78 | ||||
| Market Capitalization | 2.95 B | ||||
| Total Asset | 614.32 M | ||||
| Retained Earnings | (1.24 B) | ||||
| Working Capital | 275.77 M | ||||
| Net Asset | 614.32 M |
About Twist Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 989 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.